STOCK TITAN

Soleno Therapeutics, Inc. (SLNO) Net Income by Year

SLNO

Soleno Therapeutics, Inc. reported $20.9M in net income in fiscal year 2025. This represents an increase of 111.9% from the prior fiscal year. The table below carries 13 fiscal years, from 2013 to 2025, and the quarters Soleno Therapeutics, Inc. has filed alongside them.

FY2025 annual
Net Income $20.9M
YoY +111.9%
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

SLNO Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-K
Net Income$20.9M+111.9%-$175.8M-351.0%-$39.0M-62.0%-$24.1M+22.1%-$30.9M-25.5%-$24.6M+19.9%-$30.8M-130.8%-$13.3M+13.3%-$15.4M-27.5%-$12.1M+24.2%-$15.9M-20.2%-$13.2M-257.1%-$3.7M

SLNO Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-Q
Net Income$31.4M+171.7%N/A$26.0M+134.0%-$4.7M+78.5%-$43.8M-104.6%N/A-$76.6M-605.4%-$21.9M-157.9%-$21.4M-156.1%N/A-$10.9M-77.1%-$8.5M-26.0%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Soleno Therapeutics, Inc. financials

Frequently Asked Questions

What was Soleno Therapeutics, Inc.'s net income in fiscal year 2025?

Soleno Therapeutics, Inc. reported $20.9M in net income in fiscal year 2025.

How fast is Soleno Therapeutics, Inc.'s net income growing?

Soleno Therapeutics, Inc. (SLNO) net income rose by 111.9% year over year, from -$175.8M to $20.9M in fiscal year 2025.

How has Soleno Therapeutics, Inc.'s net income changed over the years?

Across the 13 fiscal years this page covers, Soleno Therapeutics, Inc. (SLNO) net income went from -$3.7M in fiscal year 2013 to $20.9M in fiscal year 2025.

Soleno Therapeutics, Inc. (SLNO) reported $31.4M in net income in Q1 2026. This represents an increase of 171.7% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Soleno Therapeutics, Inc. (SLNO) reported on that line in every period on record.